AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26228480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolstered usual care plus a family-level economic strengthening intervention (Suubi-Maka treatment arm)
Number of subjects: 346
Study 26228480 — intervention group
Group type: COMPARATOR
Intervention: Usual care (counseling, school uniforms, school lunch, notebooks, and textbooks) with mentorship (control condition)
Number of subjects: 346
Study 24992418 — intervention group
Group type: EXPERIMENTAL
Intervention: Care influenced by the surgical Apgar score (SAS)
Number of subjects: 143
Study 24992418 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care (Control)
Number of subjects: 143
Study 21292625 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug Burden Index (DBI)
Number of subjects: 115
Study 21292625 — intervention group
Group type: COMPARATOR
Intervention: Beers criteria
Number of subjects: 115
Study 21158218 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive exercise program (90 minutes/day, two days/week for 12 weeks) with lifestyle modification counseling
Number of subjects: 38
Study 21158218 — intervention group
Group type: COMPARATOR
Intervention: Conventional counseling at an out-patient clinic
Number of subjects: 38
Study 17914954 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg for 2 days and 1 hour before the test
Number of subjects: 13
Study 17914954 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment (Control)
Number of subjects: 13
Study 16199834 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (10-20 mg/day)
Number of subjects: 548
Study 16199834 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone (80-160 mg/day)
Number of subjects: 548
Study 11809341 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg tibolone (Livial) daily for 12 months
Number of subjects: 85
Study 11809341 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 12 months
Number of subjects: 85
Study 11809341 — intervention group
Group type: COMPARATOR
Intervention: Comparison between tibolone and placebo
Number of subjects: 85
Study 10052765 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone (S)
Number of subjects: 79
Study 10052765 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing + 25% tetracycline fibers (S+Tet)
Number of subjects: 79
Study 10052765 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing + 2% minocycline gel (S+Min)
Number of subjects: 79
Study 10052765 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing + 25% metronidazole gel (S+Met)
Number of subjects: 79
Study 7485940 — intervention group
Group type: EXPERIMENTAL
Intervention: Predeposited autologous blood transfusion (PABT)
Number of subjects: 0
Study 7485940 — intervention group
Group type: COMPARATOR
Intervention: Intra/postoperative blood salvage
Number of subjects: 0
Study 7485940 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of blood salvage and three units of PABT
Number of subjects: 0
Study 7485940 — intervention group
Group type: COMPARATOR
Intervention: Cost comparison of blood salvage
Number of subjects: 0
Study 1967729 — intervention group
Group type: COMPARATOR
Intervention: Outpatient care
Number of subjects: 141
Study 1967729 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admission
Number of subjects: 141
Study 7422399 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB) 100 mg at bedtime for the last few weeks of pregnancy
Number of subjects: 2863
Study 7422399 — intervention group
Group type: COMPARATOR
Intervention: Control group (no phenobarbital treatment)
Number of subjects: 2863
Study 7422399 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB) group
Number of subjects: 2863
Study 7422399 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2863
Study 7422399 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with moderate or marked jaundice (bilirubin > 12 mg/dl)
Number of subjects: 2863
Study 31526875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR4056 (100 mg bid for women; 200 mg bid for men)
Number of subjects: 213
Study 31526875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 31526875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR4056 in metabolic OA phenotype (BMI ≥ 27.5 kg/m2, N = 156)
Number of subjects: 213
Study 31526875 — intervention group
Group type: EXPERIMENTAL
Intervention: CR4056 in neuropathic or inflammatory phenotype
Number of subjects: 213
Study 30969174 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness app
Number of subjects: 90
Study 30969174 — intervention group
Group type: COMPARATOR
Intervention: Behavioral self-monitoring electronic diary (e-diary)
Number of subjects: 90
Study 28283195 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP care
Number of subjects: 174
Study 28283195 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 174
Study 26016861 — intervention group
Group type: COMPARATOR
Intervention: High egg (HE) meal (150 g scrambled whole eggs)
Number of subjects: 16
Study 26016861 — intervention group
Group type: COMPARATOR
Intervention: Low egg (LE) meal (75 g scrambled whole eggs)
Number of subjects: 16
Study 26016861 — intervention group
Group type: COMPARATOR
Intervention: Control meal (no egg)
Number of subjects: 16
Study 26016861 — intervention group
Group type: COMPARATOR
Intervention: High egg (HE) meal
Number of subjects: 16
Study 23958768 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized decision support system for ADHD diagnosis and treatment guidelines.
Number of subjects: 84
Study 23958768 — intervention group
Group type: COMPARATOR
Intervention: Control group (no computerized decision support system).
Number of subjects: 84
Study 20884642 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for PND using the Edinburgh Postnatal Depression Scale (EPDS)
Number of subjects: 462
Study 20884642 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment for PND screening (Control)
Number of subjects: 462
Study 19263929 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based fire safety training
Number of subjects: 59
Study 19263929 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 17503435 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related support groups
Number of subjects: 1844
Study 17503435 — intervention group
Group type: EXPERIMENTAL
Intervention: Support group perception
Number of subjects: 1844
Study 17503435 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician recommendation for support groups
Number of subjects: 1844
Study 15302282 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist + recombinant LH (75 IU/day)
Number of subjects: 42
Study 15302282 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist alone (C)
Number of subjects: 42
Study 11536410 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity-dependent method (16-18 mL of gadolinium)
Number of subjects: 54
Study 11536410 — intervention group
Group type: COMPARATOR
Intervention: High-dose method (38 mL of gadolinium)
Number of subjects: 54
Study 9491873 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 17beta-estradiol (E2), 1 mg daily, combined sequentially with dydrogesterone 5 or 10 mg (14 days per 28-day treatment cycle) for 12 months, then E2, 2 mg daily, combined with dydrogesterone, 10 mg daily (14 days per 28-day treatment cycle) for 3 months
Number of subjects: 27
Study 9491873 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 27
Study 8061720 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern analysis method for assessing successful weight reduction
Number of subjects: 0
Study 3380504 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia with meperidine by pump
Number of subjects: 130
Study 3380504 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injection of meperidine
Number of subjects: 130
Study 30548928 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia surgical care tour (4 educational videos and automated reminders to take medications)
Number of subjects: 121
Study 30548928 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham platform)
Number of subjects: 121
Study 28545493 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily testing with standard feedback (glucose values reported immediately)
Number of subjects: 0
Study 28545493 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily testing with enhanced patient feedback (glucose values reported immediately plus automated tailored feedback messaging)
Number of subjects: 0
Study 28545493 — intervention group
Group type: COMPARATOR
Intervention: No testing
Number of subjects: 0
Study 25437509 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised therapy (n=89)
Number of subjects: 233
Study 25437509 — intervention group
Group type: COMPARATOR
Intervention: Home-based therapy (n=36)
Number of subjects: 233
Study 25437509 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised therapy (high performers, n=70)
Number of subjects: 233
Study 25437509 — intervention group
Group type: COMPARATOR
Intervention: Home-based therapy (high performers, n=38)
Number of subjects: 233
Study 25437509 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised therapy and Home-based therapy (WOMAC subscales)
Number of subjects: 233
Study 22789392 — intervention group
Group type: EXPERIMENTAL
Intervention: interpositional non-ceramic hydroxylapatite bone graft
Number of subjects: 12
Study 22789392 — intervention group
Group type: COMPARATOR
Intervention: interpositional intra-oral autogenous bone graft
Number of subjects: 12
Study 21482437 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducational intervention (FPEI)
Number of subjects: 0
Study 21482437 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance focused intervention (TAFI)
Number of subjects: 0
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Naltrexone (NTX) treatment 3 times per week for 12 weeks
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Voucher-based incentives (VBI) for attendance
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational counseling (MI)
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Study medication (NTX)
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath alcohol testing
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting alcohol use
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall benefits reported by patients
Number of subjects: 90
Study 19591067 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall benefits reported by providers
Number of subjects: 90
Study 16406224 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa-IPV booster vaccine
Number of subjects: 0
Study 15291288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic nonplatinum chemotherapy
Number of subjects: 273
Study 15291288 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusions
Number of subjects: 273
Study 15291288 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 273
Study 11702325 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (5‐10 mg/kg/h) and remifentanil (0.125‐1.0 microgram/kg/min)
Number of subjects: 120
Study 11702325 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (1.0‐1.5 MAC) and remifentanil (0.125‐1.0 microgram/kg/min)
Number of subjects: 120
Study 11702325 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 9389861 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 20 micrograms kg‐1, propofol 2.5 mg kg‐1 and vecuronium 0.1 mg kg‐1
Number of subjects: 60
Study 9389861 — intervention group
Group type: COMPARATOR
Intervention: thiopentone 5 mg kg‐1 and suxamethonium 1 mg kg‐1
Number of subjects: 60
Study 7932942 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive anxiety with increasing heart rate
Number of subjects: 8
Study 7932942 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive anxiety with decreasing heart rate
Number of subjects: 8
Study 7932942 — intervention group
Group type: COMPARATOR
Intervention: Low cognitive anxiety
Number of subjects: 8
Study 3286173 — intervention group
Group type: EXPERIMENTAL
Intervention: PPA 75 mg SR
Number of subjects: 288
Study 3286173 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 288
Study 3286173 — intervention group
Group type: EXPERIMENTAL
Intervention: PPA SR 75 mg with caffeine 200 mg
Number of subjects: 288
Study 3286173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study 28707491 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplement (1g fish oil)
Number of subjects: 95
Study 28707491 — intervention group
Group type: COMPARATOR
Intervention: Placebo (free of oil)
Number of subjects: 95
Study 28707491 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplement
Number of subjects: 95
Study 28707491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 27718414 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based behavior therapy (ABBT)
Number of subjects: 0
Study 27718414 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation (AR)
Number of subjects: 0
Study 26571323 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative forced-air warming for 20 min
Number of subjects: 50
Study 26571323 — intervention group
Group type: COMPARATOR
Intervention: Control group (no warming)
Number of subjects: 50
Study 24156397 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time contact-based educational intervention
Number of subjects: 111
Study 24156397 — intervention group
Group type: COMPARATOR
Intervention: Multimodal undergraduate psychiatry course
Number of subjects: 111
Study 24156397 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigma towards mental illness
Number of subjects: 111
Study 20871194 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 252
Study 20871194 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 252
Study 20871194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 18377622 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum enriched in marine compounds
Number of subjects: 0
Study 18377622 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream formulation
Number of subjects: 0
Study 18377622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotion and cream formulations
Number of subjects: 0
Study 18377622 — intervention group
Group type: COMPARATOR
Intervention: No treatment (after stopping treatment)
Number of subjects: 0
Study 17313803 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg/d for 7 days before surgery
Number of subjects: 75
Study 17313803 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of celecoxib 200 mg/d and octreotide 100 microg injected subcutaneously for 7 days before surgery
Number of subjects: 75
Study 17313803 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anti‐tumor medicine before GC resection)
Number of subjects: 75
Study 12682082 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone (50 to 200 mg daily)
Number of subjects: 269
Study 12682082 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (2.5 to 10 mg daily)
Number of subjects: 269
Study 10067694 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined, short schedule group (Co-S) - DTaP and PRP-T vaccines reconstituted immediately prior to injection at 3, 4 and 5 months of age
Number of subjects: 410
Study 10067694 — intervention group
Group type: EXPERIMENTAL
Intervention: Associated, short schedule group (As-S) - DTaP + PRP-T simultaneously injected at different sites at 3, 4 and 5 months of age
Number of subjects: 410
Study 10067694 — intervention group
Group type: EXPERIMENTAL
Intervention: Associated, long schedule group (As-L) - DTaP + PRP-T at separate sites at 2, 4 and 6 months
Number of subjects: 410
Study 10067694 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster vaccination with unconjugated PRP
Number of subjects: 410
Study 10067694 — intervention group
Group type: COMPARATOR
Intervention: DTwP (whole-cell) vaccine
Number of subjects: 410
Study 8537258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 93
Study 8537258 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 93
Study 8537258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole and Itraconazole
Number of subjects: 93
Study 2378547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride 10 mg daily
Number of subjects: 53
Study 2378547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride 20 mg daily
Number of subjects: 53
Study 2378547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride 30 mg daily
Number of subjects: 53
Study 2378547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride (various doses)
Number of subjects: 53
Study 2378547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride (doses over 0.3 mg/kg per day)
Number of subjects: 53
Study 19025 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 4 mg/70 kg i.m.
Number of subjects: 20
Study 19025 — intervention group
Group type: COMPARATOR
Intervention: Morphine 10 mg/70 kg i.m.
Number of subjects: 20
Study 31448111 — intervention group
Group type: EXPERIMENTAL
Intervention: Samata intervention (structural and norms-based intervention)
Number of subjects: 2457
Study 31448111 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2457
Study 31448111 — intervention group
Group type: EXPERIMENTAL
Intervention: Samata intervention
Number of subjects: 2457
Study 31448111 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2457
Study 27831738 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + WIRED (online writing intervention)
Number of subjects: 34
Study 27831738 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 34
Study 25308309 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hand-movement observation task
Number of subjects: 30
Study 25308309 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 30
Study 24902920 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment targeting systolic blood pressure <120 mm Hg
Number of subjects: 9361
Study 24902920 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment targeting systolic blood pressure <140 mm Hg
Number of subjects: 9361
Study 23082836 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS and Hepatitis Health Promotion (HHP) program led by nurses
Number of subjects: 154
Study 23082836 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Messaging (AM) program led by artists
Number of subjects: 154
Study 19528834 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Resistance Training (SRT)
Number of subjects: 0
Study 19528834 — intervention group
Group type: EXPERIMENTAL
Intervention: All-round Physical Exercise (APE)
Number of subjects: 0
Study 19528834 — intervention group
Group type: COMPARATOR
Intervention: Reference Intervention (REF)
Number of subjects: 0
Study 17288688 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 20
Study 17288688 — intervention group
Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 20
Study 15354524 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha1‐adrenoceptor blocker (Terazosin 2 mg qn) and Levo‐ofloxacin (0.2 bid)
Number of subjects: 80
Study 15354524 — intervention group
Group type: COMPARATOR
Intervention: Levo‐ofloxacin (0.2 bid) alone
Number of subjects: 80
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous constrictor band
Number of subjects: 0
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 0
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernous injection with prostaglandin E1
Number of subjects: 0
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile vibratory stimulation (PVS)
Number of subjects: 0
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroejaculation (EEJ)
Number of subjects: 0
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: Home insemination with semen obtained by PVS
Number of subjects: 0
Study 11571657 — intervention group
Group type: EXPERIMENTAL
Intervention: PVS or EEJ combined with assisted reproduction techniques
Number of subjects: 0
Study 9829447 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelaic acid 20% cream and glycolic acid 15% or 20% lotion
Number of subjects: 100
Study 9829447 — intervention group
Group type: COMPARATOR
Intervention: Hydroquinone 4% cream
Number of subjects: 100
Study 8008725 — intervention group
Group type: EXPERIMENTAL
Intervention: dicloxacillin 500 mg 3 times a day
Number of subjects: 9
Study 8008725 — intervention group
Group type: COMPARATOR
Intervention: dicloxacillin 250 mg + probenecid 250 mg 3 times a day
Number of subjects: 9
Study 3619135 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprofylline 2.5 mg/kg
Number of subjects: 135
Study 3619135 — intervention group
Group type: COMPARATOR
Intervention: Theophylline (standard dose)
Number of subjects: 135
Study 31240752 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual family intervention (n=49)
Number of subjects: 97
Study 31240752 — intervention group
Group type: COMPARATOR
Intervention: Group intervention (n=48)
Number of subjects: 97
Study 31240752 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 97
Study 31240752 — intervention group
Group type: COMPARATOR
Intervention: Group intervention
Number of subjects: 97
Study 29280239 — intervention group
Group type: EXPERIMENTAL
Intervention: www.scottga.org
Number of subjects: 176
Study 29280239 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 176
Study 29280239 — intervention group
Group type: COMPARATOR
Intervention: Placebo hand-washing game
Number of subjects: 176
Study 26867559 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured skill training (n = 10)
Number of subjects: 20